Enterprise AI
by George Leopold
April 8, 2019
Nvidia is collaborating with medical groups to push GPU-powered AI tools into clinical settings, including radiology and drug discovery.
The GPU leader said Monday (April 8) it will collaborate with the American College of Radiology (ACR) to provide clinicians with its Clara AI tool kit. The partnership would allow radiologists to leverage AI techniques for diagnostic imaging using their own clinical data.
Nvidia (NASDAQ: NVDA) announced a separate AI partnership with the medical consortium, Accelerating Therapeutics for Opportunities, or ATOM, to speed the drug discovery process and reduce the number of false starts. The effort combines “AI, high-performance computing, and advanced experimental technologies intended to help shorten the drug discovery timeline,” the partners said...
